1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	751_ANS_clinical_caseMIR	SENT1	-	-
2	naloxona	naloxona	NC00SC0	C0027358	producto#sustancia	12-20	751_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
3	,	,	Fc	-	-	20-21	751_ANS_clinical_caseMIR	SENT1	-	-
4	flumazenilo	flumazenilo	NC00BO0	-	-	22-33	751_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	y	y	CC	C1706368	calificador	34-35	751_ANS_clinical_caseMIR	SENT1	-	-
6	tiamina	tiamina	NCFS000	C0039840	sustancia	36-43	751_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
7	.	.	Fp	-	-	43-44	751_ANS_clinical_caseMIR	SENT1	-	-

1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	751_ANS_clinical_caseMIR	SENT2	-	-
2	naloxona	naloxona	NC00SC0	C0027358	producto#sustancia	12-20	751_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
3	,	,	Fc	-	-	20-21	751_ANS_clinical_caseMIR	SENT2	-	-
4	flumazenilo	flumazenilo	NC00BO0	-	-	22-33	751_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
5	y	y	CC	C1706368	calificador	34-35	751_ANS_clinical_caseMIR	SENT2	-	-
6	glucosa	glucosa	NCFS000	C0017725	sustancia#producto	36-43	751_ANS_clinical_caseMIR	SENT2	-	-
7	hipert贸nica	hipert贸nica	NCFS000	-	-	44-55	751_ANS_clinical_caseMIR	SENT2	-	-
8	.	.	Fp	-	-	55-56	751_ANS_clinical_caseMIR	SENT2	-	-

1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	751_ANS_clinical_caseMIR	SENT3	-	-
2	naloxona	naloxona	NC00SC0	C0027358	producto#sustancia	12-20	751_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
3	y	y	CC	C1706368	calificador	21-22	751_ANS_clinical_caseMIR	SENT3	-	-
4	flumazenilo	flumazenilo	NC00BO0	-	-	23-34	751_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
5	.	.	Fp	-	-	34-35	751_ANS_clinical_caseMIR	SENT3	-	-

1	Administrar	administrar	VMN0000	C1621583	calificador	0-11	751_ANS_clinical_caseMIR	SENT4	-	-
2	tiamina	tiamina	NCFS000	C0039840	sustancia	12-19	751_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
3	y	y	CC	C1706368	calificador	20-21	751_ANS_clinical_caseMIR	SENT4	-	-
4	glucosa	glucosa	NCFS000	C0017725	sustancia#producto	22-29	751_ANS_clinical_caseMIR	SENT4	-	-
5	hipert贸nica	hipert贸nica	NCFS000	-	-	30-41	751_ANS_clinical_caseMIR	SENT4	-	-
6	.	.	Fp	-	-	41-42	751_ANS_clinical_caseMIR	SENT4	-	-

